Viewing StudyNCT00182052



Ignite Creation Date: 2024-05-05 @ 11:56 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00182052
Status: COMPLETED
Last Update Posted: 2013-05-23
First Post: 2005-09-14

Brief Title: Rosiglitazone Avandia vs Placebo for Androgen Dependent Prostate Cancer
Sponsor: Massachusetts General Hospital
Organization: Massachusetts General Hospital

Conditions & Keywords Data

Conditions:
Name
Prostate Cancer
Adenocarcinoma of the Prostate
Keywords:
Name View
rosiglitazone View
Avandia View
androgen dependant prostate cancer View